Nuvalent (NUVL) Net Cash Flow (2020 - 2026)
Nuvalent (NUVL) posted Net Cash Flow of -$102.0 million for Q1 2026, down 169.87% on a QoQ basis from $146.0 million in Q4 2025, and down 310.41% year-over-year from $48.5 million in Q1 2025.
Nuvalent (NUVL) Net Cash Flow (2020 - 2026) Analysis & Trends
Nuvalent's Net Cash Flow history runs 7 years deep, the most recent figure standing at -$102.0 million for Q1 2026.
- Quarterly Net Cash Flow fell 310.41% year-over-year to -$102.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.9 million (up 74.27% YoY) and the FY2025 annual result came in at $116.1 million, up 161.18% from the prior year.
- Net Cash Flow was -$102.0 million for Q1 2026 at Nuvalent, down from $146.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $291.5 million in Q3 2024 and bottomed at -$236.9 million in Q1 2024.
- A 5-year average of $5.4 million and a median of -$1.3 million in 2022 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 4312.56% in 2023, while the deepest fall reached 12006.23% in 2023.
- Nuvalent's Net Cash Flow stood at $165.5 million in 2022, then surged by 49.22% to $247.0 million in 2023, then plunged by 190.52% to -$223.6 million in 2024, then soared by 165.31% to $146.0 million in 2025, then sank by 169.87% to -$102.0 million in 2026.
- Business Quant data shows NUVL's Net Cash Flow at -$102.0 million in Q1 2026, $146.0 million in Q4 2025, and -$11.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 224.46 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 57.19 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | -102.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.01 Mn |
| Mar 31, 2026 | -102.01 Mn |
| Dec 31, 2025 | 145.99 Mn |
| Dec 31, 2025 | 145.99 Mn |
| Sep 30, 2025 | -11.72 Mn |
| Sep 30, 2025 | -11.72 Mn |
| Jun 30, 2025 | 6.64 Mn |
| Jun 30, 2025 | 6.64 Mn |
| Mar 31, 2025 | -24.86 Mn |
| Mar 31, 2025 | -24.86 Mn |
| Dec 31, 2024 | -223.55 Mn |
| Dec 31, 2024 | -223.55 Mn |
| Sep 30, 2024 | 291.54 Mn |
| Sep 30, 2024 | 291.54 Mn |
| Jun 30, 2024 | -20.82 Mn |
| Jun 30, 2024 | -20.82 Mn |
| Mar 31, 2024 | -236.87 Mn |
| Mar 31, 2024 | -236.87 Mn |
| Dec 31, 2023 | 246.95 Mn |
| Dec 31, 2023 | 246.95 Mn |